"Today, the US Food and Drug Administration (FDA) issued an emergency authorization for Pfizer's Paxlovid to treat mild to moderate coronavirus disease in adults and pediatric patients ..."

Earlier it was reported that experts under the US medical regulator CDC recommended, if possible, not to use the Johnson & Johnson coronavirus vaccine due to complications with blood clots.